Coverage
-
June 23, 2014
The Patent Trial and Appeal Board on Friday invalidated many claims of four dietary supplement patents that Swiss Merck KgaA accused biotech firm Gnosis SpA of infringing, in what an attorney for Gnosis said may be the first inter partes review involving pharmaceutical-related patents.
1 other articles on this case.
View all »